For: | Baumgart DC. What’s new in inflammatory bowel disease in 2008? World J Gastroenterol 2008; 14(3): 329-330 [PMID: 18200655 DOI: 10.3748/wjg.14.329] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i3/329.htm |
Number | Citing Articles |
1 |
Francesco Tonelli, Francesco Giudici, Gadiel Liscia. Is lymphatic status related to regression of inflammation in Crohn's disease?. World Journal of Gastrointestinal Surgery 2012; 4(10): 228-233 doi: 10.4240/wjgs.v4.i10.228
|
2 |
David Benharush, Matan J Cohen, Yair Kasirer, Dan Turner. Short chain fatty acids (butyrate) for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2010; doi: 10.1002/14651858.CD008730
|
3 |
Lin Deng, Jin-Feng Zhou, Rani S. Sellers, Jiu-Feng Li, Andrew V. Nguyen, Yubao Wang, Amos Orlofsky, Qiang Liu, David A. Hume, Jeffrey W. Pollard, Leonard Augenlicht, Elaine Y. Lin. A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis. The American Journal of Pathology 2010; 176(2): 952 doi: 10.2353/ajpath.2010.090622
|
4 |
Rebekka Mueller, Farah Ziade, Valérie Pittet, Nicolas Fournier, Jessica Ezri, Alain Schoepfer, Susanne Schibli, Johannes Spalinger, Christian Braegger, Andreas Nydegger. Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?. Journal of Crohn's and Colitis 2016; 10(3): 269 doi: 10.1093/ecco-jcc/jjv199
|
5 |
Anastassios C. Manolakis, Andreas N. Kapsoritakis, Anastasia Kapsoritaki, Elisavet K. Tiaka, Konstantinos A. Oikonomou, Vassilis Lotis, Dimitra Vamvakopoulou, Ioanna Davidi, Nikolaos Vamvakopoulos, Spyros P. Potamianos. Readressing the Role of Toll-Like Receptor-4 Alleles in Inflammatory Bowel Disease: Colitis, Smoking, and Seroreactivity. Digestive Diseases and Sciences 2012; doi: 10.1007/s10620-012-2348-4
|
6 |
Raj Kumar, Tamanna Islam, Md Nurunnabi. Mucoadhesive carriers for oral drug delivery. Journal of Controlled Release 2022; 351: 504 doi: 10.1016/j.jconrel.2022.09.024
|
7 |
Helga-Paula Török, Burkhard Göke, Astrid Konrad. Pharmacogenetics of Crohn‘s Disease. Pharmacogenomics 2008; 9(7): 881 doi: 10.2217/14622416.9.7.881
|
8 |
Eric Lui. Systemic Causes of Heel Pain. Clinics in Podiatric Medicine and Surgery 2010; 27(3): 431 doi: 10.1016/j.cpm.2010.04.004
|
9 |
Esra Küpeli Akkol, Büşra Karpuz, Eduardo Sobarzo-Sánchez, Haroon Khan. A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitis. Food and Chemical Toxicology 2020; 144: 111628 doi: 10.1016/j.fct.2020.111628
|
10 |
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
|
11 |
L.H. Lian, T.P. Lau, V.L. Lee, W.S. Lee, I. Hilmi, K.L. Goh, K.H. Chua. Lack of association between TYK2 and STAT3 genes and Crohn’s disease in the Malaysian population. Genetics and Molecular Research 2013; 12(1): 167 doi: 10.4238/2013.January.24.9
|
12 |
Franca Viola, Fortunata Civitelli, Giovanni Di Nardo, Maria Beatrice Barbato, Osvaldo Borrelli, Salvatore Oliva, Francesca Conte, Salvatore Cucchiara. Efficacy of Adalimumab in Moderate-to-Severe Pediatric Crohn's Disease. The American Journal of Gastroenterology 2009; 104(10): 2566 doi: 10.1038/ajg.2009.372
|